La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Cadrenal Therapeutics a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Cadrenal Therapeutics..

Cadrenal Therapeutics (NASDAQ:CVKD) Azioni, Catena delle Opzioni

CADRENAL THERAPEUTICS INC

Cadrenal Therapeutics

Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.

Cadrenal Therapeutics, Inc. - Common Stock

Cadrenal Therapeutics Inc

Press Releases

Cadrenal Therapeutics to Present at Inaugural Centri Capital Conference at Nasdaq

Cadrenal Therapeutics Reports First-Quarter 2025 Financial Results and Provides Corporate Update

News

$34 Billion Market in 2025 Advancing to $45 Billion in 2026 for Phase III Development of New Blood Thiner, Less Problematic Than Warfrain: Cadrenal Therapeutics, Inc. (Nasdaq: CVKD)

Cadrenal Therapeutics Announces Tecarfarin Manufacturing Progress in Support of Clinical Trial Readiness

Cadrenal Therapeutics to Engage Potential Partners at BIO International Convention 2025

Cadrenal Therapeutics Highlights New Research on Anticoagulation Burden for LVAD Patients

Cadrenal Therapeutics Announces Clinical Trial Initiation Plans for Tecarfarin in Patients with End-Stage Kidney Disease (ESKD) Transitioning to Dialysis

Cadrenal Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Health Care

Cadrenal Therapeutics Enhances Anticoagulation Pipeline Through Acquisition of eXIthera's Portfolio of Factor XIa Inhibitors

Cadrenal Therapeutics to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025

CVKD

AN2 Therapeutics

Aspire Biopharma Holdings, Inc. - Common Stock

Aspire Biopharma Hldgs

Athira Pharma

Aytu BioPharma

CalciMedica

Cingulate

Clearside Biomedical, Inc. - Common Stock

Clearside Biomedical

Citius Pharmaceuticals, Inc. - Common Stock

Citius Pharmaceuticals

Curanex Pharmaceuticals Inc - Common Stock

Curanex Pharmaceuticals

Dare Bioscience

Hoth Therapeutics

IGC Pharma

Iterum Therapeutics

Lexaria Bioscience

MIRA Pharmaceuticals, Inc. - Common Stock

Mira Pharmaceuticals

NLS Pharmaceutics Ltd Ordinary Shares

Processa Pharmaceuticals, Inc. - Common Stock

Processa Pharmaceuticals

Pulmatrix

PolyPid

SCYNEXIS

SenesTech

Traws Pharma

Tvardi Therapeutics

Veru

Verrica Pharmaceuticals Inc. - Common Stock

Verrica Pharmaceuticals

HC Wainwright & Co.

Noble Capital Markets

Comments

Cadrenal Therapeutics

Cadrenal Therapeutics (CVKD) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO